ライフサイエンスコーパス: periconceptional

1 Periconceptional administration of folic acid can reduce

2 the association between maternal reports of periconceptional alcohol consumption and clefting.

3 d with that of 9 infants born to women whose periconceptional alcohol intake averaged > or = 30mL abs

4 This study examined the effects of maternal periconceptional alcohol intake on polyunsaturated fatty

5 Periconceptional alcohol use was associated with a 30% i

6 trol study, we investigated whether parental periconceptional cigarette smoking was associated with a

7 Periconceptional diet may persistently influence DNA met

8 The authors investigated whether maternal periconceptional dietary intakes of choline and its meta

9 ian adults and show, in rural Gambians, that periconceptional environment affects offspring VTRNA2-1

10 rential DNA methylation in whole blood after periconceptional exposure to famine during the Dutch Hun

11 To determine whether periconceptional exposure to folic acid antagonists (FAA

12 nvestigated the association between maternal periconceptional exposure to nitrate from drinking water

13 associations between neural tube defects and periconceptional exposure to NSDs containing a secondary

14 Periconceptional exposure to Ramadan was associated with

15 Mean IQs were higher in children exposed to periconceptional folate (108, 95% CI 106-111) than they

16 Mechanisms whereby periconceptional folate influences normal development an

17 Periconceptional folate is essential for proper neurodev

18 ide future analyses of the causal effects of periconceptional folate levels on candidate pathways.

19 The positive association of periconceptional folate with IQ is consistent with other

20 ised dose, gestational birth age, and use of periconceptional folate.

21 Periconceptional folic acid may reduce ASD risk in those

22 ore substantial evidence about the effect of periconceptional folic acid on the occurrence of congeni

23 In the 1990s, the utility of periconceptional folic acid supplementation and folic ac

24 Periconceptional folic acid supplementation and food for

25 ndings do not support an association between periconceptional folic acid supplementation and increase

26 Periconceptional folic acid supplementation is a primary

27 Periconceptional folic acid supplementation reduces the

28 Periconceptional folic acid supplementation reduces the

29 lts are adjusted for region, interview year, periconceptional folic acid supplementation, maternal ag

30 a bifida cases can be prevented by maternal, periconceptional folic acid supplementation.

31 Periconceptional intake of 400 microg of folic acid dail

32 Periconceptional intake of folic acid prevents some neur

33 interaction between infant RFC1 genotype and periconceptional intake of vitamins on the risk of conot

34 uality evidence of the effect of prenatal or periconceptional iodine supplementation on growth and co

35 ic health nurse (aOR, 0.2; 95% CI, 0.1-0.8), periconceptional maternal alcohol use (aOR, 6.2; 95% CI,

36 The hypothesis that periconceptional maternal micronutrient supplementation

37 al, and it provides suggestive evidence that periconceptional maternal nutrition alters offspring met

38 Periconceptional maternal use of cocaine (odds ratio (OR

39 lind randomized-controlled trial of pre- and periconceptional micronutrient supplementation (includin

40 A randomized controlled trial of periconceptional micronutrient supplementation in The Ga

41 Significant effects of periconceptional micronutrient supplementation were also

42 lacental vascular function was modifiable by periconceptional micronutrient supplementation.

43 We tested the hypothesis that periconceptional multiple-micronutrient supplementation

44 Information is summarized for periconceptional multivitamin or folic acid intake, whic

45 The association between periconceptional multivitamin use and PTBs varied accord

46 ective was to determine the relation between periconceptional multivitamin use and the risk of small-

47 The timing and frequency of periconceptional multivitamin use may be related to the

48 to assess the independent effect of regular periconceptional multivitamin use on the risk of preecla

49 We related the timing and frequency of periconceptional multivitamin use to SGA births and PTBs

50 Regular periconceptional multivitamin use was associated with a

51 ment gestational age, and household density, periconceptional multivitamin use was associated with a

52 Periconceptional multivitamin use was associated with a

53 Early studies suggested that periconceptional multivitamin use was associated with an

54 Regular periconceptional multivitamin use was associated with re

55 Periconceptional multivitamin use, defined as reported r

56 psia (2.3%), and 18,551 women (65%) reported periconceptional multivitamin use.

57 major cardiac defects could be prevented by periconceptional multivitamin use.

58 lded inconsistent results for the effects of periconceptional multivitamins containing folic acid and

59 The intake of periconceptional multivitamins may decrease the risk of

60 Periconceptional NSAIDs reported through the sixth week

61 cted from 1998 to 2012, we compared maternal periconceptional NSD use between 334 neural tube defect

62 atively small, these pilot data suggest that periconceptional nutrition in humans is an important det

63 ntified as changes observed after randomized periconceptional nutritional supplementation in a Gambia

64 Gender-specific changes related to periconceptional nutritional supplementation were identi

65 The asthma medications used during the periconceptional period (1 month prepregnancy through th

66 terval (CI): 1.00, 3.67), smoking during the periconceptional period (aOR = 2.09, 95% CI: 1.08, 4.03)

67 lements and dietary intakes during a 6-month periconceptional period (from 3 months before conception

68 folate-only supplement use during a 12-week periconceptional period (from 4 weeks prior to 8 weeks a

69 s and 3 sources of social support during the periconceptional period among mothers of 593 gastroschis

70 urse visits, maternal alcohol use during the periconceptional period and first trimester, and layers

71 e can be altered by maternal diet during the periconceptional period and that these programming event

72 en maternal asthma medication use during the periconceptional period and the risk of gastroschisis.

73 Maternal nutrition exclusively during the periconceptional period can induce remarkable effects on

74 Daily folic acid supplementation in the periconceptional period can prevent neural tube defects.

75 dine supplementation during pregnancy or the periconceptional period in regions of severe iodine defi

76 perimental animals, maternal diet during the periconceptional period influences the establishment of

77 ular use of a multivitamin supplement in the periconceptional period may help to prevent preeclampsia

78 dine supplementation during pregnancy or the periconceptional period on the development and growth of

79 Although adequate folate intake during the periconceptional period prevents neural tube defects, an

80 s that folic acid supplementation during the periconceptional period reduces the risk of oral clefts.

81 hypotheses that maternal exposure during the periconceptional period to multivitamins or liver consum

82 Exposure to G/R infections during the periconceptional period was associated with a significan

83 Maternal smoking during the periconceptional period was not associated with risk of

84 rs of multiple asthma medications during the periconceptional period were also examined.

85 significant ORs for use that began after the periconceptional period were observed for cleft palate o

86 daily folic acid supplementation during the periconceptional period were: oral clefts, 1.1 (95% conf

87 the first trimester (or first trimester and periconceptional period), with no reports of birth defec

88 is that maternal micronutrient status in the periconceptional period, and throughout pregnancy and la

89 supplements containing folic acid during the periconceptional period, the number of children born wit

90 clomiphene (without ART) and ART during the periconceptional period.

91 water at home, and dietary intake during the periconceptional period.

92 idence for higher risk of CL/P with maternal periconceptional smoking in infants with an NOS3 -922G a

93 Periconceptional supplement use did not reduce the risk

94 e, and public health guidelines recommending periconceptional supplementation have increased folic ac

95 n the absence of clinical folate deficiency, periconceptional supplementation with folic acid reduces

96 Animal models show that periconceptional supplementation with folic acid, vitami

97 risk of neural tube defects is decreased by periconceptional supplementation with folic acid.

98 In conclusion, twinning and periconceptional undernutrition are associated with epig

99 to gestational timing categories, including periconceptional use (28 days before through 28 days aft

100 etween cases and controls assessing maternal periconceptional use of folic acid and intake of dietary

101 Periconceptional use of folic acid containing supplement

102 support a protective association between the periconceptional use of folic acid supplements and the r

103 1%, 25.2%, and 26.1%, respectively, reported periconceptional use of folic acid supplements.

104 k among the fetuses or infants of women with periconceptional use of folic acid was also significant

105 ong the fetuses or infants of the women with periconceptional use of folic acid, the rates were 1.0 p

106 The periconceptional use of folic acid-containing supplement

107 other birth defects may be prevented by the periconceptional use of folic acid.

108 rs investigated whether maternal or paternal periconceptional use of recreational drugs increased the

109 ube defect risk was associated with maternal periconceptional use of secondary (adjusted odds ratio (

110 known for the past two decades that maternal periconceptional use of the B vitamin folic acid can pre

111 Maternal periconceptional use of vitamin supplements containing f

112 teraction between the RFC1 gene and maternal periconceptional use of vitamins containing folic acid.

113 ubgroup of women in the northern region with periconceptional use who took folic acid pills more than

114 In contrast, prenatal and periconceptional use, compared with nonuse, were not rel

115 For periconceptional use, ORs with 95% confidence intervals

116 These data support the hypothesis that periconceptional vitamin supplementation may extend bene

117 rol infants for whom information on maternal periconceptional vitamin use was available.

118 m births and extreme SGA in women who report periconceptional vitamin use, although these should be c

119 After adjustment for race, body mass index, periconceptional vitamin use, and gestational age at sam